NSE filing, NSE: PANACHE. Summary written from the filing by ALFA Finder's alert engine.
Panache Digilife Ltd: key numbers
- Share price
- ₹672.60
- Market cap
- ₹1,088 Cr
- Revenue (annual)
- ₹243.0 Cr
- Net profit (annual)
- ₹16.18 Cr
- P/E (TTM)
- 40.6×Sector 41.6×
- Promoter holding
- 54.05%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Panache Digilife Ltd
All →Panache Digilife Bags ₹51.43 Cr Order from Domestic customer in IT sector
Panache Digilife received a work order to supply laptops with accessories, valued at Rs. 51.43 crore excluding GST. Execution is expected within about 30 days.
- Value
- ₹51.43 Cr
- From
- Domestic customer in IT sector (awarding entity name not disclosed)
- Execution
- Approximately 30 days
Panache Digilife Capital Structure Change
Panache Digilife invested Rs 2.25 Crore via rights issue in wholly owned subsidiary Technofy Digital. The subsidiary remains 100% owned, with nil turnover reported.
- Value
- ₹2.25 Cr
Panache Digilife Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹12,960 lakh (+231.8% YoY), Op EBITDA margin 9.6%, PAT ₹770 lakh (+450.8%). Strategy: DLM mix shift, telecom and AI expansion.
Panache Digilife Results Update
Panache Digilife's Q2 FY27 Total Income rose 231.7% YoY to ₹13,075 Lakhs; PAT reached ₹770 Lakhs. The press release accompanies unaudited quarterly results approved by the board.
Panache Digilife Convertible Warrants
Panache Digilife allotted 1,60,300 equity shares on conversion of preferential warrants after receiving Rs 3.16 Crore in exercise money. Paid-up capital rises to Rs 16.17 Crore.
- Value
- ₹3.16 Cr
Panache Digilife Q2 FY27 Results: Net Profit ₹9.3 Cr, Up 564.3% YoY
Panache Digilife Ltd reported revenue from operations of ₹129.6 Cr (+231.5% YoY) and net profit of ₹9.3 Cr (+564.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.3 Cr · +564.3% YoY
Other employee stock options announcements
All →Sai Life Science Employee Stock Options
Sai Life Sciences allotted 108,005 ESOP equity shares, taking paid-up capital to Rs.21.26 Crore. No stated consideration means no event value.
Billionbrains Garage Ventures Employee Stock Options
Billionbrains Garage Ventures granted 21,63,086 stock options to eligible employees under its 2024 ESOP scheme. Each option carries an exercise price of Rs. 2 per share.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Zensar Technologies Employee Stock Options
Zensar Technologies allotted 31,440 equity shares to employees on exercise of ESOPs. Paid-up share capital rose to ₹45.55 crore across 22.78 crore shares.
IIFL Finance Employee Stock Options
IIFL Finance allotted 1,97,523 equity shares to eligible employees on exercise of ESOPs, approved by the NRC on 5 November 2026. No cash consideration per share is stated in the filing.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.